Link

Content

Korean Bio Institute Develops Cancer Diagnostic Technology Using Gene Editing

Dr. Kang Tae-jun's team at the Bio-Nano Research Center of the Korea Research Institute of Bioscience and Biotechnology (KRIBB), in collaboration with Massachusetts General Hospital (MGH), Harvard Medical School (HMS), and Sungkyunkwan University, announced on the 5th that they have developed a technology to diagnose cancer using a blood test with gene editing tools. The research team has developed an innovative cancer diagnostic system, SCOPE, which significantly improves the detection of biomarkers present in bodily fluids. This system allows for the simultaneous testing of 16 individuals in just 40 minutes and has been miniaturized for enhanced portability.